Abdallah Sassine Geara, MD
Associate Professor of Clinical Medicine (Renal-Electrolyte and Hypertension)
Clinical Director, Glomerular Diseases Program, University of Pennsylvania
Director, Renal PCAM clinic, University of Pennsylvania
Director, The OncoNephrology Program, The University of Pennsylvania
Department: Medicine
Contact information
Renal, Electrolyte and Hypertension Division
The Hospital of the University of Pennsylvania, 1 Founders Pavilion
3400 spruce street
Philadelphia, PA 19104
The Hospital of the University of Pennsylvania, 1 Founders Pavilion
3400 spruce street
Philadelphia, PA 19104
Office: 215-662-2638
Fax: 215-615-0349
Fax: 215-615-0349
Education:
MD (Doctor of Medicine)
Lebanese University-Faculty of Medical Sciences, 2005.
Permanent linkMD (Doctor of Medicine)
Lebanese University-Faculty of Medical Sciences, 2005.
Description of Clinical Expertise
Onconephrology (Renal diseases in Cancer Patients)Glomerular Disease
Renal Amyloidosis
Kidney Vasculitis
Lupus Nephritis
Proteinuria
Hematuria
kidney biopsy
Description of Research Expertise
Glomerular diseasesOnconephrology
kidney biopsy
Selected Publications
Reza Zonozi, MD, Faten Aqeel, MD, Dustin Le, MD, Frank B. Cortazar, MD, Jugal Thaker, MD, Maria Jose Zabala Ramirez, MD, Sebastian Eduardo Sattui Cortes, MD, Rose Mary Attieh, MD, Madeline Chung, MD, David H. Bulbin, DO, Aisha Shaikh, MD, Karina Guaman, BA, Julia Ford, MD, Colin Diffie, MD, Ora Gewurz-Singer, MD, Gabriel Sauvage, BS, Anushya Jeyabalan, MD, Abdallah Geara, MD, Isabelle Ayoub, MD, Andrew Bomback, MD, Lara L. Khoury, MD, Jason C. George, DO, Kenar D. Jhaveri, MD, Vimal Kumar Derebail, MD, John L. Niles, MD, Duvuru Geetha, MD: "Real-world experience with avacopan in ANCA-associated vasculitis" Kidney International Reports March 2024.Michelle N Rheault 1, Charles E Alpers 1, Jonathan Barratt 1, Stewart Bieler 1, Pietro Canetta 1, Dong-Wan Chae 1, Gaia Coppock 1, Ulysses Diva 1, Loreto Gesualdo 1, Hiddo J L Heerspink 1, Jula K Inrig 1, Gianna M Kirsztajn 1, Donald Kohan 1, Radko Komers 1, Laura A Kooienga 1, Kenneth Lieberman 1, Alex Mercer 1, Irene L Noronha 1, Vlado Perkovic 1, Jai Radhakrishnan 1, William Rote 1, Brad Rovin 1, Vladimir Tesar 1, Hernán Trimarchi 1, James Tumlin 1, Muh Geot Wong 1, Howard Trachtman 1; DUPRO Steering Committee and DUPLEX Investigators: "Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis" NEJM december 2023.
Rovin, B, et al,: "Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial" Lancet november 2023.
Hiddo J L Heerspink 1, Jai Radhakrishnan 2, Charles E Alpers 3, Jonathan Barratt 4, Stewart Bieler 5, Ulysses Diva 6, Jula Inrig 6, Radko Komers 6, Alex Mercer 7, Irene L Noronha 8, Michelle N Rheault 9, William Rote 6, Brad Rovin 10, Howard Trachtman 11, Hernán Trimarchi 12, Muh Geot Wong 13, Vlado Perkovic 14; PROTECT Investigators: "Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial" Lancet May 2023.
Vinay Srinivasan, Bader Kfoury, Sarah Ahmad, Jordana Cohen, and Abdallah S Geara: Long term outcomes of bevacizumab-associated kidney adverse effects. Journal of Onco-Nephrology october 2022.
Amudala NA, Boukhlal S, Sheridan B, Langford CA, Geara A, Merkel PA, Cornec D.: "Obinutuzumab as Treatment for ANCA-Associated Vasculitis" Rheumatology (Oxford). december 2021.
Srinivasan V, Geara AS, Han S, Hogan JJ, Coppock G.: "Need for symptom monitoring in IgA nephropathy patients post COVID-19 vaccination" Clin Nephrol december 2021.
Liann Abu Salman, Christos Kallis, Matthew Palmer, Jehan Bahrainwala, Abdallah S Geara: "New-Onset Proteinuria in a Patient With Schwannoma" American Journal Of Kidney Disease september 2021.
Shahrzad Zonoozi , Matthew Palmer , Teitelbaum Ursina , Abdallah Geara : "Worsening membranous nephropathy in a patient with GIST treated with sunitinib" BMJ Case Rep 14(8), august 2021.
Triebwasser MP, Barrett DM, Bassiri H, Bunin N, Elgarten C, Freedman J, Geara AS, Monos D, Lambert MP, Olson T, Seif AE, Paessler M, Petrosa W, Reilly AF, Romberg N, Sullivan KE, Quinn GZ, Behrens E, Teachey DT.: Combined use of emapalumab and ruxolitinib in a patient with refractory hemophagocytic lymphohistiocytosis was safe and effective. Pediatric and Blood Cancer july 2021.